Literature DB >> 6779089

[Isolation of a strain of Trypanosoma cruzi from a patient with chronic Chagas cardiomyopathy and its biological characterization].

S M González Cappa, P Chiale, G E del Prado, A M Katzin, G W de Martini, E D de Isola, L Abramo Orrego, E L Segura.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6779089

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN： 0025-7680            Impact factor:   0.653


× No keyword cloud information.
  10 in total

1.  Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice.

Authors:  E Castaños-Velez; S Maerlan; L M Osorio; F Aberg; P Biberfeld; A Orn; M E Rottenberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner.

Authors:  Catalina D Alba Soto; Gerardo A Mirkin; Maria E Solana; Stella M González Cappa
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Surface proteins in different isolates of Trypanosoma cruzi epimastigotes.

Authors:  N S Gonzalez; D O Sanchez; A C Frasch; I D Algranati
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

4.  Direct micromethod for diagnosis of acute and congenital Chagas' disease.

Authors:  H Feilij; L Muller; S M Gonzalez Cappa
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Authors:  Estela I Batalla; Agustina M Pino Martínez; Carolina V Poncini; Tomás Duffy; Alejandro G Schijman; Stella M González Cappa; Catalina D Alba Soto
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

6.  A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.

Authors:  N W Zwirner; E L Malchiodi; M G Chiaramonte; C A Fossati
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Purification and characterization of an 80-kilodalton Trypanosoma cruzi urinary antigen.

Authors:  R S Corral; A Orn; H L Freilij; T Bergman; S Grinstein
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

8.  Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.

Authors:  Ágata C Cevey; Gerardo A Mirkin; Martín Donato; María J Rada; Federico N Penas; Ricardo J Gelpi; Nora B Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-07       Impact factor: 4.077

9.  Quantification by real-time PCR of Trypanosoma cruzi DNA in samples of Triatoma infestans used in xenodiagnosis of chronic Chagas disease patients.

Authors:  Miguel Saavedra; Inés Zulantay; Werner Apt; Juan Castillo; Eduardo Araya; Gabriela Martínez; Jorge Rodríguez
Journal:  Parasit Vectors       Date:  2016-07-04       Impact factor: 3.876

10.  Lipids From Trypanosoma cruzi Amastigotes of RA and K98 Strains Generate a Pro-inflammatory Response via TLR2/6.

Authors:  Emanuel Bott; Alan B Carneiro; Guadalupe Gimenez; María G López; Estela M Lammel; Georgia C Atella; Patricia T Bozza; María L Belaunzarán
Journal:  Front Cell Infect Microbiol       Date:  2018-05-08       Impact factor: 5.293
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.